Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease (Q33979298)

30 July 2017

title

Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease (English)

1 reference

autosomal dominant polycystic kidney

30 July 2017

main subject

1 reference

Marie C Hogan

1

1 reference

30 July 2017

Tetyana V Masyuk

2

1 reference

30 July 2017

Linda J Page

3

1 reference

30 July 2017

Vickie J Kubly

4

1 reference

30 July 2017

Eric J Bergstralh

5

1 reference

30 July 2017

Xujian Li

6

1 reference

30 July 2017

Bohyun Kim

7

1 reference

30 July 2017

Bernard F King

8

1 reference

30 July 2017

James Glockner

9

1 reference

30 July 2017

David R Holmes

10

1 reference

30 July 2017

Sandro Rossetti

11

1 reference

30 July 2017

Peter C Harris

12

1 reference

30 July 2017

Nicholas F LaRusso

13

1 reference

30 July 2017

Vicente E Torres

14

1 reference

30 July 2017

publication date

29 April 2010

1 reference

Journal of the American Society of Nephrology

30 July 2017

published in

1 reference

30 July 2017

volume

21

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

1052-1061

1 reference

Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Autosomal dominant polycystic kidney disease: the last 3 years

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Use of somatostatin analogues in obesity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Antitumor effects of somatostatin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Sirolimus reduces polycystic liver volume in ADPKD patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Selective, concurrent bilateral nephrectomies at renal transplantation for autosomal dominant polycystic kidney disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Mutations in SEC63 cause autosomal dominant polycystic liver disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

The benefit of stereology for quantitative radiology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Signal transduction of somatostatin receptors negatively controlling cell proliferation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegaly.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

New software toolkits for comprehensive visualization and analysis of three-dimensional multimodal biomedical images

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Somatostatin: an endogenous peptide in the toad urinary bladder inhibits vasopressin-stimulated water flow

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Somatostatin and alpha 2-adrenergic agonists selectively inhibit vasopressin-induced cyclic AMP accumulation in MDCK cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Hepatic cysts in autosomal dominant polycystic kidney disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Effects of long term octreotide on gall stone formation and gall bladder function

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Somatostatin analogues reduce liver volume in polycystic liver disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Octreotide-induced bradycardia and heart block during surgical resection of a carcinoid tumor

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Hair loss in three patients with acromegaly treated with octreotide

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

MEK inhibits secretin release and pancreatic secretion: roles of secretin-releasing peptide and somatostatin

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2900957

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

29 October 2018

1 reference

12 December 2020

Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Effect of somatostatin on renal water handling in the dog

1 reference

12 December 2020

Effect of somatostatin on vasopressin-induced antidiuresis and renal cyclic AMP of rats

1 reference

12 December 2020

Octreotide and loss of scalp hair

1 reference

12 December 2020

Octreotide decreases biliary and pancreatic exocrine function, and induces steatorrhea in healthy subjects

1 reference

12 December 2020

Scalp hair loss caused by octreotide in a patient with acromegaly: a case report

1 reference

12 December 2020

Isolation and characterization of rat cholangiocyte vesicles enriched in apical or basolateral plasma membrane domains

1 reference

12 December 2020

Development of a nonisotopic capillary electrophoresis-based method for measuring glomerular filtration rate

1 reference

12 December 2020

Octreotide-induced bradycardia

1 reference

12 December 2020

Volume progression in polycystic kidney disease

1 reference

12 December 2020

Autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2009121291

1 reference

30 July 2017

1 reference

30 July 2017

1 reference